{
  "iteration": 158,
  "question_id": "index_157",
  "results_by_threshold": {
    "0.65": {
      "detected_pairs": [
        {
          "chain1_id": "q158_c1",
          "chain2_id": "q158_c3",
          "thought1_idx": 4,
          "thought2_idx": 3,
          "text1": "Wait, but what's the exact mechanism of dominant-negative in this scenario. The mutant Y might form faulty dimers with wild-type, making them unable to function. So the overall result is that the transcription factor can't dimerize correctly, so it can't enter the nucleus and activate genes. So the outcome is loss of function.\n\nLooking at the options again:\n\nOption D says protein aggregation and loss of function. So perhaps the mutant Y causes the proteins to aggregate, making them unable to function. That would fit.",
          "text2": "Wait, let's break it down. The transcription factor needs to dimerize to function. Mutation Y is in the dimerization domain and is dominant-negative. So when Y is present (heterozygous), the mutant subunit will form a dimer with the wild-type subunit.\n\nBut does that dimer work? Since it's a dominant-negative, the dimer probably can't function correctly. So the transcription factor can't dimerize properly, which is needed for its activity. So the cells can't transcribe the genes. That's a loss-of-function.\n\nBut what about the actual molecular effect? So the Y mutation would prevent dimerization because the dimerization domain is messed up. So the proteins can't form the dimers needed. So the dimerization is lost.\n\nLooking at the options, option D says protein aggregation and loss-of-function. But I'm not sure if the dimerization issue would cause aggregation.",
          "score": 0.8919724822044373
        },
        {
          "chain1_id": "q158_c3",
          "chain2_id": "q158_c4",
          "thought1_idx": 4,
          "thought2_idx": 4,
          "text1": "Wait, the question is about the molecular phenotype. So in the presence of Y, the protein can't form proper dimers because the Y mutation is in the dimerization domain. So the dimerization doesn't happen, which means the transcription factor doesn't function. That's a loss-of-function.\n\nSo which option says that? Let's look.\n\nOption B: protein degradation and loss of wild-type allele. Hmm, I don't think Y would cause degradation of the protein. It might just interfere with its function.\n\nOption D: aggregation and loss. Maybe if the proteins can't dimerize, they might form aggregates. But I'm not certain.",
          "text2": "Wait, dominant-negative mutations often lead to the mutant and wild-type proteins not working together. So the presence of Y would prevent dimerization. So the protein can't dimerize, so it stays in the cytoplasm and doesn't enter the nucleus. So the phenotype is loss of function.\n\nLooking again at the options, what's the molecular phenotype? So the question is about the effect on the protein when Y is present. Y is in the dimerization domain. So if the protein can't dimerize, it can't function.\n\nOption B says loss of function of the wild-type allele. But in a heterozygote, both alleles are expressed. Y is dominant-negative, meaning that the presence of Y affects the wild-type protein. So perhaps the mutant Y prevents the wild-type from functioning. So the wild-type protein's function is lost because the mutant interferes.\n\nSo the effect is that the transcription factor can't dimerize, so it can't function. So the phenotype is loss of function.\n\nOption D says loss of dimerization and loss of function. But the options are:\n\nOption B: protein degradation and loss of function of wild-type. So if Y leads to the protein being degraded, then the wild-type would lose function because the protein is broken down.\n\nBut I'm not sure if Y would lead to degradation.",
          "score": 0.9078274965286255
        },
        {
          "chain1_id": "q158_c2",
          "chain2_id": "q158_c4",
          "thought1_idx": 5,
          "thought2_idx": 2,
          "text1": "Alternatively, maybe the mutant proteins can't dimerize, so each remains monomeric and can't enter the nucleus. But whether they aggregate is another thing.\n\nOption B mentions protein degradation. I don't think the mutation Y would cause the protein to be degraded unless there's a quality control issue, which isn't mentioned here.",
          "text2": "Alternatively, if the mutant Y is dominant-negative, it might cause the wild-type proteins to not form proper dimers, leading to them not functioning. So the cells can't transcribe the gene, which is loss of function.\n\nSo looking at the options, option D says protein aggregation and loss-of-function.",
          "score": 0.7942132353782654
        },
        {
          "chain1_id": "q158_c1",
          "chain2_id": "q158_c4",
          "thought1_idx": 6,
          "thought2_idx": 5,
          "text1": "Another way to think: Mutation Y is dominant-negative, so it inhibits the function of both alleles (the mutant Y and the wild-type). So the cell can't form functional dimers because the mutant Y disrupts the dimer formation. If the proteins can't dimerize, they can't go into the nucleus and activate genes. So the phenotype is loss of function.\n\nIn terms of molecular changes, if the dimerization is lost, the proteins might not be able to function. Additionally, if the mutant Y leads to the formation of aggregates, that's another possibility. So option D says protein aggregation and loss of function. That could be the case.",
          "text2": "Alternatively, let's think about dominant-negative mutations. They usually work by the mutant protein interfering with the normal allele's function. So when a cell is heterozygous (one wild-type, one Y), the Y mutant might form nonfunctional dimers with the wild-type subunits, preventing the normal function.\n\nSo the wild-type allele's function is lost because the mutant allele is dominant-negative, leading to the inability to form functional dimers. So the overall effect is loss of function.\n\nLooking at the options:\n\nOption D: protein aggregation and loss-of-function. So if the mutant Y leads to proteins aggregating (like forming insoluble structures), that would prevent them from functioning. So the phenotype would be a loss of function.\n\nOption B: protein degradation. Is Y causing the proteins to be broken down? I'm not sure. It depends on how the mutation affects the protein. For example, if the dimerization domain is messed up, the protein might not be recognized correctly and perhaps be targeted for degradation. Or maybe the mutant is just non-functional but not degraded.\n\nIf the proteins can't dimerize, maybe they remain in the cytoplasm and don't go to the nucleus, but whether they get degraded or not is unclear.",
          "score": 0.9196065068244934
        },
        {
          "chain1_id": "q158_c1",
          "chain2_id": "q158_c2",
          "thought1_idx": 10,
          "thought2_idx": 5,
          "text1": "Another thought: since Y is in the dimerization domain, maybe it can't form dimers. So the mutant Y subunits can't form dimers with each other or with wild-type. So, perhaps the mutant Y proteins accumulate in the cytoplasm, unable to form the necessary complexes.",
          "text2": "Alternatively, maybe the mutant proteins can't dimerize, so each remains monomeric and can't enter the nucleus. But whether they aggregate is another thing.\n\nOption B mentions protein degradation. I don't think the mutation Y would cause the protein to be degraded unless there's a quality control issue, which isn't mentioned here.",
          "score": 0.7848953604698181
        },
        {
          "chain1_id": "q158_c3",
          "chain2_id": "q158_c2",
          "thought1_idx": 11,
          "thought2_idx": 11,
          "text1": "Alternatively, perhaps the presence of Y causes the proteins to form nonfunctional dimers, but not necessarily degrade or aggregate. But the options don't have that.",
          "text2": "Alternatively, the presence of Y could lead to the inability to dimerize, so the proteins are monomeric and not functional, but not necessarily aggregated.\n\nThe question is about the molecular phenotype observed. So the presence of Y would prevent dimerization, leading to non-functional proteins. But looking at the options, the only one that mentions loss of dimerization is... none of the options explicitly mention that. Let me check.",
          "score": 0.8467258214950562
        }
      ],
      "num_detected": 6,
      "num_same_answer": 3,
      "same_answer_perc": 50.0
    },
    "0.7": {
      "detected_pairs": [
        {
          "chain1_id": "q158_c1",
          "chain2_id": "q158_c3",
          "thought1_idx": 4,
          "thought2_idx": 3,
          "text1": "Wait, but what's the exact mechanism of dominant-negative in this scenario. The mutant Y might form faulty dimers with wild-type, making them unable to function. So the overall result is that the transcription factor can't dimerize correctly, so it can't enter the nucleus and activate genes. So the outcome is loss of function.\n\nLooking at the options again:\n\nOption D says protein aggregation and loss of function. So perhaps the mutant Y causes the proteins to aggregate, making them unable to function. That would fit.",
          "text2": "Wait, let's break it down. The transcription factor needs to dimerize to function. Mutation Y is in the dimerization domain and is dominant-negative. So when Y is present (heterozygous), the mutant subunit will form a dimer with the wild-type subunit.\n\nBut does that dimer work? Since it's a dominant-negative, the dimer probably can't function correctly. So the transcription factor can't dimerize properly, which is needed for its activity. So the cells can't transcribe the genes. That's a loss-of-function.\n\nBut what about the actual molecular effect? So the Y mutation would prevent dimerization because the dimerization domain is messed up. So the proteins can't form the dimers needed. So the dimerization is lost.\n\nLooking at the options, option D says protein aggregation and loss-of-function. But I'm not sure if the dimerization issue would cause aggregation.",
          "score": 0.8919724822044373
        },
        {
          "chain1_id": "q158_c3",
          "chain2_id": "q158_c4",
          "thought1_idx": 4,
          "thought2_idx": 4,
          "text1": "Wait, the question is about the molecular phenotype. So in the presence of Y, the protein can't form proper dimers because the Y mutation is in the dimerization domain. So the dimerization doesn't happen, which means the transcription factor doesn't function. That's a loss-of-function.\n\nSo which option says that? Let's look.\n\nOption B: protein degradation and loss of wild-type allele. Hmm, I don't think Y would cause degradation of the protein. It might just interfere with its function.\n\nOption D: aggregation and loss. Maybe if the proteins can't dimerize, they might form aggregates. But I'm not certain.",
          "text2": "Wait, dominant-negative mutations often lead to the mutant and wild-type proteins not working together. So the presence of Y would prevent dimerization. So the protein can't dimerize, so it stays in the cytoplasm and doesn't enter the nucleus. So the phenotype is loss of function.\n\nLooking again at the options, what's the molecular phenotype? So the question is about the effect on the protein when Y is present. Y is in the dimerization domain. So if the protein can't dimerize, it can't function.\n\nOption B says loss of function of the wild-type allele. But in a heterozygote, both alleles are expressed. Y is dominant-negative, meaning that the presence of Y affects the wild-type protein. So perhaps the mutant Y prevents the wild-type from functioning. So the wild-type protein's function is lost because the mutant interferes.\n\nSo the effect is that the transcription factor can't dimerize, so it can't function. So the phenotype is loss of function.\n\nOption D says loss of dimerization and loss of function. But the options are:\n\nOption B: protein degradation and loss of function of wild-type. So if Y leads to the protein being degraded, then the wild-type would lose function because the protein is broken down.\n\nBut I'm not sure if Y would lead to degradation.",
          "score": 0.9078274965286255
        },
        {
          "chain1_id": "q158_c2",
          "chain2_id": "q158_c4",
          "thought1_idx": 5,
          "thought2_idx": 2,
          "text1": "Alternatively, maybe the mutant proteins can't dimerize, so each remains monomeric and can't enter the nucleus. But whether they aggregate is another thing.\n\nOption B mentions protein degradation. I don't think the mutation Y would cause the protein to be degraded unless there's a quality control issue, which isn't mentioned here.",
          "text2": "Alternatively, if the mutant Y is dominant-negative, it might cause the wild-type proteins to not form proper dimers, leading to them not functioning. So the cells can't transcribe the gene, which is loss of function.\n\nSo looking at the options, option D says protein aggregation and loss-of-function.",
          "score": 0.7942132353782654
        },
        {
          "chain1_id": "q158_c1",
          "chain2_id": "q158_c4",
          "thought1_idx": 6,
          "thought2_idx": 5,
          "text1": "Another way to think: Mutation Y is dominant-negative, so it inhibits the function of both alleles (the mutant Y and the wild-type). So the cell can't form functional dimers because the mutant Y disrupts the dimer formation. If the proteins can't dimerize, they can't go into the nucleus and activate genes. So the phenotype is loss of function.\n\nIn terms of molecular changes, if the dimerization is lost, the proteins might not be able to function. Additionally, if the mutant Y leads to the formation of aggregates, that's another possibility. So option D says protein aggregation and loss of function. That could be the case.",
          "text2": "Alternatively, let's think about dominant-negative mutations. They usually work by the mutant protein interfering with the normal allele's function. So when a cell is heterozygous (one wild-type, one Y), the Y mutant might form nonfunctional dimers with the wild-type subunits, preventing the normal function.\n\nSo the wild-type allele's function is lost because the mutant allele is dominant-negative, leading to the inability to form functional dimers. So the overall effect is loss of function.\n\nLooking at the options:\n\nOption D: protein aggregation and loss-of-function. So if the mutant Y leads to proteins aggregating (like forming insoluble structures), that would prevent them from functioning. So the phenotype would be a loss of function.\n\nOption B: protein degradation. Is Y causing the proteins to be broken down? I'm not sure. It depends on how the mutation affects the protein. For example, if the dimerization domain is messed up, the protein might not be recognized correctly and perhaps be targeted for degradation. Or maybe the mutant is just non-functional but not degraded.\n\nIf the proteins can't dimerize, maybe they remain in the cytoplasm and don't go to the nucleus, but whether they get degraded or not is unclear.",
          "score": 0.9196065068244934
        },
        {
          "chain1_id": "q158_c1",
          "chain2_id": "q158_c2",
          "thought1_idx": 10,
          "thought2_idx": 5,
          "text1": "Another thought: since Y is in the dimerization domain, maybe it can't form dimers. So the mutant Y subunits can't form dimers with each other or with wild-type. So, perhaps the mutant Y proteins accumulate in the cytoplasm, unable to form the necessary complexes.",
          "text2": "Alternatively, maybe the mutant proteins can't dimerize, so each remains monomeric and can't enter the nucleus. But whether they aggregate is another thing.\n\nOption B mentions protein degradation. I don't think the mutation Y would cause the protein to be degraded unless there's a quality control issue, which isn't mentioned here.",
          "score": 0.7848953604698181
        },
        {
          "chain1_id": "q158_c3",
          "chain2_id": "q158_c2",
          "thought1_idx": 11,
          "thought2_idx": 11,
          "text1": "Alternatively, perhaps the presence of Y causes the proteins to form nonfunctional dimers, but not necessarily degrade or aggregate. But the options don't have that.",
          "text2": "Alternatively, the presence of Y could lead to the inability to dimerize, so the proteins are monomeric and not functional, but not necessarily aggregated.\n\nThe question is about the molecular phenotype observed. So the presence of Y would prevent dimerization, leading to non-functional proteins. But looking at the options, the only one that mentions loss of dimerization is... none of the options explicitly mention that. Let me check.",
          "score": 0.8467258214950562
        }
      ],
      "num_detected": 6,
      "num_same_answer": 3,
      "same_answer_perc": 50.0
    },
    "0.75": {
      "detected_pairs": [
        {
          "chain1_id": "q158_c1",
          "chain2_id": "q158_c3",
          "thought1_idx": 4,
          "thought2_idx": 3,
          "text1": "Wait, but what's the exact mechanism of dominant-negative in this scenario. The mutant Y might form faulty dimers with wild-type, making them unable to function. So the overall result is that the transcription factor can't dimerize correctly, so it can't enter the nucleus and activate genes. So the outcome is loss of function.\n\nLooking at the options again:\n\nOption D says protein aggregation and loss of function. So perhaps the mutant Y causes the proteins to aggregate, making them unable to function. That would fit.",
          "text2": "Wait, let's break it down. The transcription factor needs to dimerize to function. Mutation Y is in the dimerization domain and is dominant-negative. So when Y is present (heterozygous), the mutant subunit will form a dimer with the wild-type subunit.\n\nBut does that dimer work? Since it's a dominant-negative, the dimer probably can't function correctly. So the transcription factor can't dimerize properly, which is needed for its activity. So the cells can't transcribe the genes. That's a loss-of-function.\n\nBut what about the actual molecular effect? So the Y mutation would prevent dimerization because the dimerization domain is messed up. So the proteins can't form the dimers needed. So the dimerization is lost.\n\nLooking at the options, option D says protein aggregation and loss-of-function. But I'm not sure if the dimerization issue would cause aggregation.",
          "score": 0.8919724822044373
        },
        {
          "chain1_id": "q158_c3",
          "chain2_id": "q158_c4",
          "thought1_idx": 4,
          "thought2_idx": 4,
          "text1": "Wait, the question is about the molecular phenotype. So in the presence of Y, the protein can't form proper dimers because the Y mutation is in the dimerization domain. So the dimerization doesn't happen, which means the transcription factor doesn't function. That's a loss-of-function.\n\nSo which option says that? Let's look.\n\nOption B: protein degradation and loss of wild-type allele. Hmm, I don't think Y would cause degradation of the protein. It might just interfere with its function.\n\nOption D: aggregation and loss. Maybe if the proteins can't dimerize, they might form aggregates. But I'm not certain.",
          "text2": "Wait, dominant-negative mutations often lead to the mutant and wild-type proteins not working together. So the presence of Y would prevent dimerization. So the protein can't dimerize, so it stays in the cytoplasm and doesn't enter the nucleus. So the phenotype is loss of function.\n\nLooking again at the options, what's the molecular phenotype? So the question is about the effect on the protein when Y is present. Y is in the dimerization domain. So if the protein can't dimerize, it can't function.\n\nOption B says loss of function of the wild-type allele. But in a heterozygote, both alleles are expressed. Y is dominant-negative, meaning that the presence of Y affects the wild-type protein. So perhaps the mutant Y prevents the wild-type from functioning. So the wild-type protein's function is lost because the mutant interferes.\n\nSo the effect is that the transcription factor can't dimerize, so it can't function. So the phenotype is loss of function.\n\nOption D says loss of dimerization and loss of function. But the options are:\n\nOption B: protein degradation and loss of function of wild-type. So if Y leads to the protein being degraded, then the wild-type would lose function because the protein is broken down.\n\nBut I'm not sure if Y would lead to degradation.",
          "score": 0.9078274965286255
        },
        {
          "chain1_id": "q158_c2",
          "chain2_id": "q158_c4",
          "thought1_idx": 5,
          "thought2_idx": 2,
          "text1": "Alternatively, maybe the mutant proteins can't dimerize, so each remains monomeric and can't enter the nucleus. But whether they aggregate is another thing.\n\nOption B mentions protein degradation. I don't think the mutation Y would cause the protein to be degraded unless there's a quality control issue, which isn't mentioned here.",
          "text2": "Alternatively, if the mutant Y is dominant-negative, it might cause the wild-type proteins to not form proper dimers, leading to them not functioning. So the cells can't transcribe the gene, which is loss of function.\n\nSo looking at the options, option D says protein aggregation and loss-of-function.",
          "score": 0.7942132353782654
        },
        {
          "chain1_id": "q158_c1",
          "chain2_id": "q158_c4",
          "thought1_idx": 6,
          "thought2_idx": 5,
          "text1": "Another way to think: Mutation Y is dominant-negative, so it inhibits the function of both alleles (the mutant Y and the wild-type). So the cell can't form functional dimers because the mutant Y disrupts the dimer formation. If the proteins can't dimerize, they can't go into the nucleus and activate genes. So the phenotype is loss of function.\n\nIn terms of molecular changes, if the dimerization is lost, the proteins might not be able to function. Additionally, if the mutant Y leads to the formation of aggregates, that's another possibility. So option D says protein aggregation and loss of function. That could be the case.",
          "text2": "Alternatively, let's think about dominant-negative mutations. They usually work by the mutant protein interfering with the normal allele's function. So when a cell is heterozygous (one wild-type, one Y), the Y mutant might form nonfunctional dimers with the wild-type subunits, preventing the normal function.\n\nSo the wild-type allele's function is lost because the mutant allele is dominant-negative, leading to the inability to form functional dimers. So the overall effect is loss of function.\n\nLooking at the options:\n\nOption D: protein aggregation and loss-of-function. So if the mutant Y leads to proteins aggregating (like forming insoluble structures), that would prevent them from functioning. So the phenotype would be a loss of function.\n\nOption B: protein degradation. Is Y causing the proteins to be broken down? I'm not sure. It depends on how the mutation affects the protein. For example, if the dimerization domain is messed up, the protein might not be recognized correctly and perhaps be targeted for degradation. Or maybe the mutant is just non-functional but not degraded.\n\nIf the proteins can't dimerize, maybe they remain in the cytoplasm and don't go to the nucleus, but whether they get degraded or not is unclear.",
          "score": 0.9196065068244934
        },
        {
          "chain1_id": "q158_c1",
          "chain2_id": "q158_c2",
          "thought1_idx": 10,
          "thought2_idx": 5,
          "text1": "Another thought: since Y is in the dimerization domain, maybe it can't form dimers. So the mutant Y subunits can't form dimers with each other or with wild-type. So, perhaps the mutant Y proteins accumulate in the cytoplasm, unable to form the necessary complexes.",
          "text2": "Alternatively, maybe the mutant proteins can't dimerize, so each remains monomeric and can't enter the nucleus. But whether they aggregate is another thing.\n\nOption B mentions protein degradation. I don't think the mutation Y would cause the protein to be degraded unless there's a quality control issue, which isn't mentioned here.",
          "score": 0.7848953604698181
        },
        {
          "chain1_id": "q158_c3",
          "chain2_id": "q158_c2",
          "thought1_idx": 11,
          "thought2_idx": 11,
          "text1": "Alternatively, perhaps the presence of Y causes the proteins to form nonfunctional dimers, but not necessarily degrade or aggregate. But the options don't have that.",
          "text2": "Alternatively, the presence of Y could lead to the inability to dimerize, so the proteins are monomeric and not functional, but not necessarily aggregated.\n\nThe question is about the molecular phenotype observed. So the presence of Y would prevent dimerization, leading to non-functional proteins. But looking at the options, the only one that mentions loss of dimerization is... none of the options explicitly mention that. Let me check.",
          "score": 0.8467258214950562
        }
      ],
      "num_detected": 6,
      "num_same_answer": 3,
      "same_answer_perc": 50.0
    },
    "0.8": {
      "detected_pairs": [
        {
          "chain1_id": "q158_c1",
          "chain2_id": "q158_c3",
          "thought1_idx": 4,
          "thought2_idx": 3,
          "text1": "Wait, but what's the exact mechanism of dominant-negative in this scenario. The mutant Y might form faulty dimers with wild-type, making them unable to function. So the overall result is that the transcription factor can't dimerize correctly, so it can't enter the nucleus and activate genes. So the outcome is loss of function.\n\nLooking at the options again:\n\nOption D says protein aggregation and loss of function. So perhaps the mutant Y causes the proteins to aggregate, making them unable to function. That would fit.",
          "text2": "Wait, let's break it down. The transcription factor needs to dimerize to function. Mutation Y is in the dimerization domain and is dominant-negative. So when Y is present (heterozygous), the mutant subunit will form a dimer with the wild-type subunit.\n\nBut does that dimer work? Since it's a dominant-negative, the dimer probably can't function correctly. So the transcription factor can't dimerize properly, which is needed for its activity. So the cells can't transcribe the genes. That's a loss-of-function.\n\nBut what about the actual molecular effect? So the Y mutation would prevent dimerization because the dimerization domain is messed up. So the proteins can't form the dimers needed. So the dimerization is lost.\n\nLooking at the options, option D says protein aggregation and loss-of-function. But I'm not sure if the dimerization issue would cause aggregation.",
          "score": 0.8919724822044373
        },
        {
          "chain1_id": "q158_c3",
          "chain2_id": "q158_c4",
          "thought1_idx": 4,
          "thought2_idx": 4,
          "text1": "Wait, the question is about the molecular phenotype. So in the presence of Y, the protein can't form proper dimers because the Y mutation is in the dimerization domain. So the dimerization doesn't happen, which means the transcription factor doesn't function. That's a loss-of-function.\n\nSo which option says that? Let's look.\n\nOption B: protein degradation and loss of wild-type allele. Hmm, I don't think Y would cause degradation of the protein. It might just interfere with its function.\n\nOption D: aggregation and loss. Maybe if the proteins can't dimerize, they might form aggregates. But I'm not certain.",
          "text2": "Wait, dominant-negative mutations often lead to the mutant and wild-type proteins not working together. So the presence of Y would prevent dimerization. So the protein can't dimerize, so it stays in the cytoplasm and doesn't enter the nucleus. So the phenotype is loss of function.\n\nLooking again at the options, what's the molecular phenotype? So the question is about the effect on the protein when Y is present. Y is in the dimerization domain. So if the protein can't dimerize, it can't function.\n\nOption B says loss of function of the wild-type allele. But in a heterozygote, both alleles are expressed. Y is dominant-negative, meaning that the presence of Y affects the wild-type protein. So perhaps the mutant Y prevents the wild-type from functioning. So the wild-type protein's function is lost because the mutant interferes.\n\nSo the effect is that the transcription factor can't dimerize, so it can't function. So the phenotype is loss of function.\n\nOption D says loss of dimerization and loss of function. But the options are:\n\nOption B: protein degradation and loss of function of wild-type. So if Y leads to the protein being degraded, then the wild-type would lose function because the protein is broken down.\n\nBut I'm not sure if Y would lead to degradation.",
          "score": 0.9078274965286255
        },
        {
          "chain1_id": "q158_c1",
          "chain2_id": "q158_c4",
          "thought1_idx": 6,
          "thought2_idx": 5,
          "text1": "Another way to think: Mutation Y is dominant-negative, so it inhibits the function of both alleles (the mutant Y and the wild-type). So the cell can't form functional dimers because the mutant Y disrupts the dimer formation. If the proteins can't dimerize, they can't go into the nucleus and activate genes. So the phenotype is loss of function.\n\nIn terms of molecular changes, if the dimerization is lost, the proteins might not be able to function. Additionally, if the mutant Y leads to the formation of aggregates, that's another possibility. So option D says protein aggregation and loss of function. That could be the case.",
          "text2": "Alternatively, let's think about dominant-negative mutations. They usually work by the mutant protein interfering with the normal allele's function. So when a cell is heterozygous (one wild-type, one Y), the Y mutant might form nonfunctional dimers with the wild-type subunits, preventing the normal function.\n\nSo the wild-type allele's function is lost because the mutant allele is dominant-negative, leading to the inability to form functional dimers. So the overall effect is loss of function.\n\nLooking at the options:\n\nOption D: protein aggregation and loss-of-function. So if the mutant Y leads to proteins aggregating (like forming insoluble structures), that would prevent them from functioning. So the phenotype would be a loss of function.\n\nOption B: protein degradation. Is Y causing the proteins to be broken down? I'm not sure. It depends on how the mutation affects the protein. For example, if the dimerization domain is messed up, the protein might not be recognized correctly and perhaps be targeted for degradation. Or maybe the mutant is just non-functional but not degraded.\n\nIf the proteins can't dimerize, maybe they remain in the cytoplasm and don't go to the nucleus, but whether they get degraded or not is unclear.",
          "score": 0.9196065068244934
        },
        {
          "chain1_id": "q158_c2",
          "chain2_id": "q158_c4",
          "thought1_idx": 6,
          "thought2_idx": 6,
          "text1": "Wait, the question is about the molecular phenotype. So the presence of Y would lead to the inability of the dimerization, which affects the function. So, the proteins can't dimerize, which is a loss. So which option matches that?\n\nOption D says loss of protein dimerization and loss of function.",
          "text2": "Alternatively, the main thing is that because of Y, the protein can't dimerize. So the inability to dimerize would prevent the transcription factor from functioning. So the molecular phenotype would be loss of dimerization, which leads to loss of function.\n\nLooking at the options again, option D says loss of dimerization and loss of function. But the options are listed as the molecular phenotypes.",
          "score": 0.8866196870803833
        },
        {
          "chain1_id": "q158_c3",
          "chain2_id": "q158_c2",
          "thought1_idx": 11,
          "thought2_idx": 11,
          "text1": "Alternatively, perhaps the presence of Y causes the proteins to form nonfunctional dimers, but not necessarily degrade or aggregate. But the options don't have that.",
          "text2": "Alternatively, the presence of Y could lead to the inability to dimerize, so the proteins are monomeric and not functional, but not necessarily aggregated.\n\nThe question is about the molecular phenotype observed. So the presence of Y would prevent dimerization, leading to non-functional proteins. But looking at the options, the only one that mentions loss of dimerization is... none of the options explicitly mention that. Let me check.",
          "score": 0.8467258214950562
        }
      ],
      "num_detected": 5,
      "num_same_answer": 2,
      "same_answer_perc": 40.0
    },
    "0.85": {
      "detected_pairs": [
        {
          "chain1_id": "q158_c1",
          "chain2_id": "q158_c3",
          "thought1_idx": 4,
          "thought2_idx": 3,
          "text1": "Wait, but what's the exact mechanism of dominant-negative in this scenario. The mutant Y might form faulty dimers with wild-type, making them unable to function. So the overall result is that the transcription factor can't dimerize correctly, so it can't enter the nucleus and activate genes. So the outcome is loss of function.\n\nLooking at the options again:\n\nOption D says protein aggregation and loss of function. So perhaps the mutant Y causes the proteins to aggregate, making them unable to function. That would fit.",
          "text2": "Wait, let's break it down. The transcription factor needs to dimerize to function. Mutation Y is in the dimerization domain and is dominant-negative. So when Y is present (heterozygous), the mutant subunit will form a dimer with the wild-type subunit.\n\nBut does that dimer work? Since it's a dominant-negative, the dimer probably can't function correctly. So the transcription factor can't dimerize properly, which is needed for its activity. So the cells can't transcribe the genes. That's a loss-of-function.\n\nBut what about the actual molecular effect? So the Y mutation would prevent dimerization because the dimerization domain is messed up. So the proteins can't form the dimers needed. So the dimerization is lost.\n\nLooking at the options, option D says protein aggregation and loss-of-function. But I'm not sure if the dimerization issue would cause aggregation.",
          "score": 0.8919724822044373
        },
        {
          "chain1_id": "q158_c3",
          "chain2_id": "q158_c4",
          "thought1_idx": 4,
          "thought2_idx": 4,
          "text1": "Wait, the question is about the molecular phenotype. So in the presence of Y, the protein can't form proper dimers because the Y mutation is in the dimerization domain. So the dimerization doesn't happen, which means the transcription factor doesn't function. That's a loss-of-function.\n\nSo which option says that? Let's look.\n\nOption B: protein degradation and loss of wild-type allele. Hmm, I don't think Y would cause degradation of the protein. It might just interfere with its function.\n\nOption D: aggregation and loss. Maybe if the proteins can't dimerize, they might form aggregates. But I'm not certain.",
          "text2": "Wait, dominant-negative mutations often lead to the mutant and wild-type proteins not working together. So the presence of Y would prevent dimerization. So the protein can't dimerize, so it stays in the cytoplasm and doesn't enter the nucleus. So the phenotype is loss of function.\n\nLooking again at the options, what's the molecular phenotype? So the question is about the effect on the protein when Y is present. Y is in the dimerization domain. So if the protein can't dimerize, it can't function.\n\nOption B says loss of function of the wild-type allele. But in a heterozygote, both alleles are expressed. Y is dominant-negative, meaning that the presence of Y affects the wild-type protein. So perhaps the mutant Y prevents the wild-type from functioning. So the wild-type protein's function is lost because the mutant interferes.\n\nSo the effect is that the transcription factor can't dimerize, so it can't function. So the phenotype is loss of function.\n\nOption D says loss of dimerization and loss of function. But the options are:\n\nOption B: protein degradation and loss of function of wild-type. So if Y leads to the protein being degraded, then the wild-type would lose function because the protein is broken down.\n\nBut I'm not sure if Y would lead to degradation.",
          "score": 0.9078274965286255
        },
        {
          "chain1_id": "q158_c1",
          "chain2_id": "q158_c4",
          "thought1_idx": 6,
          "thought2_idx": 5,
          "text1": "Another way to think: Mutation Y is dominant-negative, so it inhibits the function of both alleles (the mutant Y and the wild-type). So the cell can't form functional dimers because the mutant Y disrupts the dimer formation. If the proteins can't dimerize, they can't go into the nucleus and activate genes. So the phenotype is loss of function.\n\nIn terms of molecular changes, if the dimerization is lost, the proteins might not be able to function. Additionally, if the mutant Y leads to the formation of aggregates, that's another possibility. So option D says protein aggregation and loss of function. That could be the case.",
          "text2": "Alternatively, let's think about dominant-negative mutations. They usually work by the mutant protein interfering with the normal allele's function. So when a cell is heterozygous (one wild-type, one Y), the Y mutant might form nonfunctional dimers with the wild-type subunits, preventing the normal function.\n\nSo the wild-type allele's function is lost because the mutant allele is dominant-negative, leading to the inability to form functional dimers. So the overall effect is loss of function.\n\nLooking at the options:\n\nOption D: protein aggregation and loss-of-function. So if the mutant Y leads to proteins aggregating (like forming insoluble structures), that would prevent them from functioning. So the phenotype would be a loss of function.\n\nOption B: protein degradation. Is Y causing the proteins to be broken down? I'm not sure. It depends on how the mutation affects the protein. For example, if the dimerization domain is messed up, the protein might not be recognized correctly and perhaps be targeted for degradation. Or maybe the mutant is just non-functional but not degraded.\n\nIf the proteins can't dimerize, maybe they remain in the cytoplasm and don't go to the nucleus, but whether they get degraded or not is unclear.",
          "score": 0.9196065068244934
        },
        {
          "chain1_id": "q158_c2",
          "chain2_id": "q158_c4",
          "thought1_idx": 6,
          "thought2_idx": 6,
          "text1": "Wait, the question is about the molecular phenotype. So the presence of Y would lead to the inability of the dimerization, which affects the function. So, the proteins can't dimerize, which is a loss. So which option matches that?\n\nOption D says loss of protein dimerization and loss of function.",
          "text2": "Alternatively, the main thing is that because of Y, the protein can't dimerize. So the inability to dimerize would prevent the transcription factor from functioning. So the molecular phenotype would be loss of dimerization, which leads to loss of function.\n\nLooking at the options again, option D says loss of dimerization and loss of function. But the options are listed as the molecular phenotypes.",
          "score": 0.8866196870803833
        },
        {
          "chain1_id": "q158_c2",
          "chain2_id": "q158_c3",
          "thought1_idx": 12,
          "thought2_idx": 6,
          "text1": "Wait, option D says loss of dimerization? No, the options don't state that. Let me reread the options:\n\nOption A) Change of protein conformation and gain-of-function phenotype.\n\nNo, because Y is dominant-negative, we expect loss.\n\nOption B) Protein degradation and loss-of-function of the wild-type allele.\n\nHmm, if the mutant Y causes the normal allele's product to be degraded, that could be, but why? Maybe the mutant somehow tags the protein for degradation.\n\nOption C) Loss of protein dimerization and wild-type phenotype.\n\nNo, loss of dimerization would lead to loss of function, so the phenotype can't be wild-type.\n\nOption D) Protein aggregation and loss-of-function phenotype.\n\nSo, if the mutant Y leads to aggregation, which is a form of misfolding, then the proteins can't function. So the phenotype would be loss of function.",
          "text2": "Wait, the options detail the phenotypes. Let me read again.\n\nOption C: loss of dimerization and wild-type phenotype. No, because if dimerization is lost, the function is lost, so the phenotype would be loss-of-function, not wild-type.\n\nSo perhaps none of the options directly state that. Hmm, wait what's each option.\n\nOption D says protein aggregation and loss. If the mutant Y is in the dimerization domain, when it's in the cell, maybe the mutant and wild-type proteins try to dimerize but can't, leading to perhaps misfolded proteins that aggregate. But I'm not entirely sure if that's a common outcome.",
          "score": 0.9129898548126221
        }
      ],
      "num_detected": 5,
      "num_same_answer": 2,
      "same_answer_perc": 40.0
    },
    "0.9": {
      "detected_pairs": [
        {
          "chain1_id": "q158_c3",
          "chain2_id": "q158_c4",
          "thought1_idx": 4,
          "thought2_idx": 4,
          "text1": "Wait, the question is about the molecular phenotype. So in the presence of Y, the protein can't form proper dimers because the Y mutation is in the dimerization domain. So the dimerization doesn't happen, which means the transcription factor doesn't function. That's a loss-of-function.\n\nSo which option says that? Let's look.\n\nOption B: protein degradation and loss of wild-type allele. Hmm, I don't think Y would cause degradation of the protein. It might just interfere with its function.\n\nOption D: aggregation and loss. Maybe if the proteins can't dimerize, they might form aggregates. But I'm not certain.",
          "text2": "Wait, dominant-negative mutations often lead to the mutant and wild-type proteins not working together. So the presence of Y would prevent dimerization. So the protein can't dimerize, so it stays in the cytoplasm and doesn't enter the nucleus. So the phenotype is loss of function.\n\nLooking again at the options, what's the molecular phenotype? So the question is about the effect on the protein when Y is present. Y is in the dimerization domain. So if the protein can't dimerize, it can't function.\n\nOption B says loss of function of the wild-type allele. But in a heterozygote, both alleles are expressed. Y is dominant-negative, meaning that the presence of Y affects the wild-type protein. So perhaps the mutant Y prevents the wild-type from functioning. So the wild-type protein's function is lost because the mutant interferes.\n\nSo the effect is that the transcription factor can't dimerize, so it can't function. So the phenotype is loss of function.\n\nOption D says loss of dimerization and loss of function. But the options are:\n\nOption B: protein degradation and loss of function of wild-type. So if Y leads to the protein being degraded, then the wild-type would lose function because the protein is broken down.\n\nBut I'm not sure if Y would lead to degradation.",
          "score": 0.9078274965286255
        },
        {
          "chain1_id": "q158_c1",
          "chain2_id": "q158_c4",
          "thought1_idx": 6,
          "thought2_idx": 5,
          "text1": "Another way to think: Mutation Y is dominant-negative, so it inhibits the function of both alleles (the mutant Y and the wild-type). So the cell can't form functional dimers because the mutant Y disrupts the dimer formation. If the proteins can't dimerize, they can't go into the nucleus and activate genes. So the phenotype is loss of function.\n\nIn terms of molecular changes, if the dimerization is lost, the proteins might not be able to function. Additionally, if the mutant Y leads to the formation of aggregates, that's another possibility. So option D says protein aggregation and loss of function. That could be the case.",
          "text2": "Alternatively, let's think about dominant-negative mutations. They usually work by the mutant protein interfering with the normal allele's function. So when a cell is heterozygous (one wild-type, one Y), the Y mutant might form nonfunctional dimers with the wild-type subunits, preventing the normal function.\n\nSo the wild-type allele's function is lost because the mutant allele is dominant-negative, leading to the inability to form functional dimers. So the overall effect is loss of function.\n\nLooking at the options:\n\nOption D: protein aggregation and loss-of-function. So if the mutant Y leads to proteins aggregating (like forming insoluble structures), that would prevent them from functioning. So the phenotype would be a loss of function.\n\nOption B: protein degradation. Is Y causing the proteins to be broken down? I'm not sure. It depends on how the mutation affects the protein. For example, if the dimerization domain is messed up, the protein might not be recognized correctly and perhaps be targeted for degradation. Or maybe the mutant is just non-functional but not degraded.\n\nIf the proteins can't dimerize, maybe they remain in the cytoplasm and don't go to the nucleus, but whether they get degraded or not is unclear.",
          "score": 0.9196065068244934
        },
        {
          "chain1_id": "q158_c2",
          "chain2_id": "q158_c4",
          "thought1_idx": 9,
          "thought2_idx": 4,
          "text1": "Alternatively, perhaps the dominant-negative mutation Y leads to the formation of non-functional dimers, preventing the wild-type from functioning. So the presence of Y stops the normal function of the protein, leading to a loss of function. So the phenotype is loss of function.\n\nLooking at the options, which have loss of function? Options A, B, D.\n\nOption A is gain, so not. B and D.\n\nIn the options, B says protein degradation and wild-type allele loss. But the presence of a dominant-negative allele would lead to both alleles' function being affected. But the question is about the molecular phenotype. So, the presence of Y would interfere with the normal allele's ability to form functional dimers.\n\nSo, the wild-type protein's function is lost because it's being inhibited by the mutant Y. But the proteins themselves aren't being degraded; they're just not working because they can't dimerize.\n\nSo the molecular phenotype would be that the dimerization doesn't occur, leading to the transcription factor not being active. So the proteins are present but not functioning. So, looking at the options, which one says something about dimerization.",
          "text2": "Wait, dominant-negative mutations often lead to the mutant and wild-type proteins not working together. So the presence of Y would prevent dimerization. So the protein can't dimerize, so it stays in the cytoplasm and doesn't enter the nucleus. So the phenotype is loss of function.\n\nLooking again at the options, what's the molecular phenotype? So the question is about the effect on the protein when Y is present. Y is in the dimerization domain. So if the protein can't dimerize, it can't function.\n\nOption B says loss of function of the wild-type allele. But in a heterozygote, both alleles are expressed. Y is dominant-negative, meaning that the presence of Y affects the wild-type protein. So perhaps the mutant Y prevents the wild-type from functioning. So the wild-type protein's function is lost because the mutant interferes.\n\nSo the effect is that the transcription factor can't dimerize, so it can't function. So the phenotype is loss of function.\n\nOption D says loss of dimerization and loss of function. But the options are:\n\nOption B: protein degradation and loss of function of wild-type. So if Y leads to the protein being degraded, then the wild-type would lose function because the protein is broken down.\n\nBut I'm not sure if Y would lead to degradation.",
          "score": 0.9439605474472046
        },
        {
          "chain1_id": "q158_c2",
          "chain2_id": "q158_c3",
          "thought1_idx": 12,
          "thought2_idx": 6,
          "text1": "Wait, option D says loss of dimerization? No, the options don't state that. Let me reread the options:\n\nOption A) Change of protein conformation and gain-of-function phenotype.\n\nNo, because Y is dominant-negative, we expect loss.\n\nOption B) Protein degradation and loss-of-function of the wild-type allele.\n\nHmm, if the mutant Y causes the normal allele's product to be degraded, that could be, but why? Maybe the mutant somehow tags the protein for degradation.\n\nOption C) Loss of protein dimerization and wild-type phenotype.\n\nNo, loss of dimerization would lead to loss of function, so the phenotype can't be wild-type.\n\nOption D) Protein aggregation and loss-of-function phenotype.\n\nSo, if the mutant Y leads to aggregation, which is a form of misfolding, then the proteins can't function. So the phenotype would be loss of function.",
          "text2": "Wait, the options detail the phenotypes. Let me read again.\n\nOption C: loss of dimerization and wild-type phenotype. No, because if dimerization is lost, the function is lost, so the phenotype would be loss-of-function, not wild-type.\n\nSo perhaps none of the options directly state that. Hmm, wait what's each option.\n\nOption D says protein aggregation and loss. If the mutant Y is in the dimerization domain, when it's in the cell, maybe the mutant and wild-type proteins try to dimerize but can't, leading to perhaps misfolded proteins that aggregate. But I'm not entirely sure if that's a common outcome.",
          "score": 0.9129898548126221
        }
      ],
      "num_detected": 4,
      "num_same_answer": 1,
      "same_answer_perc": 25.0
    },
    "0.95": {
      "detected_pairs": [],
      "num_detected": 0,
      "num_same_answer": 0,
      "same_answer_perc": null
    }
  }
}